Uncover key drivers, emerging technologies, and competitive movements shaping the hand hygiene smart badges with real-time location system (rtls) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Veterinary Biomarkers Market between 2026 and 2030?

The veterinary biomarkers market has experienced substantial expansion in recent years. It is projected to increase from $0.91 billion in 2025 to $1.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.4%. The historical growth of this market can be attributed to factors such as a reliance on conventional diagnostics, limited availability of biomarkers, the escalating prevalence of animal diseases, established veterinary research methods, and the low adoption of preclinical research tools.

The veterinary biomarkers market size is projected for swift expansion in the upcoming years, reaching $1.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.0%. This growth during the forecast period is attributed to advancements in biomarker discovery, increased investment in veterinary diagnostics, heightened awareness of animal health monitoring, the expansion of companion and production animal segments, and the adoption of automated biomarker readers and digital platforms. Significant trends for the forecast period encompass the broadening of diagnostic biomarker development, the rise in predictive and prognostic biomarker applications, increasing uptake of ELISA, PCR, and rapid test kits, a growing use of advanced biomarker readers and analytical devices, and an intensifying focus on the well-being of companion and production animals.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20680&type=smp

Which Drivers Are Expected To Impact The Veterinary Biomarkers Market During The Forecast Period?

The veterinary biomarkers market is projected to experience growth due to increasing pet ownership in the future. Pet ownership refers to the condition of having one or more animals as companions, where individuals provide care, shelter, and attention to meet their animals’ requirements and welfare. Several factors contribute to the rise in pet ownership, including the desire for companionship, the advantages of pet therapy, and a growing understanding of the positive influence pets have on mental and physical well-being. Veterinary biomarkers are utilized in pet ownership for monitoring animal health, enabling early detection of diseases and the creation of personalized treatment plans. For instance, in June 2025, the Petfood Industry, a US-based organization, reported that 94 million U.S. households owned at least one pet, an increase from 82 million in 2023, indicating a substantial rise in pet ownership and an increased demand for pet care products and services. Therefore, the expanding trend of pet ownership is fueling the growth of the veterinary biomarkers market.

How Is The Veterinary Biomarkers Market Divided Into Segments?

The veterinary biomarkers market covered in this report is segmented –

1) By Product Type: Biomarkers, Kits And Reagents, Biomarker Readers

2) By Disease Type: Inflammatory And Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Other Disease Types

3) By Animal Type: Companion Animals, Production Animals

4) By Application: Disease Diagnostics, Preclinical Research, Other Applications

Subsegments:

1) By Biomarkers: Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers

2) By Kits And Reagents: ELISA Kits, PCR Kits, Western Blotting Kits, Rapid Test Kits, Reagents For Biomarker Detection

3) By Biomarker Readers: Optical Readers, Fluorescence Readers, Luminometers, Real-Time PCR Machines, Microplate Readers

How Are Emerging Trends Affecting The Progression Of The Veterinary Biomarkers Market?

Major companies in the veterinary biomarkers market are concentrating on forming strategic alliances to gain a competitive advantage. These strategic partnerships in the veterinary biomarkers field involve collaborations among companies, research institutions, and veterinary practices to advance the creation and implementation of diagnostic tools. For instance, in November 2025, Bionote USA, a US-based company focused on veterinary diagnostics, launched the Vcheck C1 In-Clinic Chemistry Analyzer. This affordable, compact biochemistry testing device is designed to expand point-of-care biomarker and diagnostic capabilities for veterinary practices. The Vcheck C1 enables the simultaneous analysis of up to 24 biochemical parameters from small animal samples in 10–12 minutes, delivering laboratory-grade accuracy with a simple workflow. It supports testing across 34 species, including canine, feline, equine, and bovine patients, with validated reference ranges for each species. Featuring broad test panels such as comprehensive chemistry, electrolyte, liver, kidney, and diabetes profiles, the analyzer helps clinicians quickly diagnose and monitor health conditions without sending samples to external labs. The product’s affordable pricing and multi-species support aim to enhance access to rapid, in-clinic biomarker diagnostics for a wide range of veterinary settings.

Which Major Firms Are Strengthening Their Position In The Veterinary Biomarkers Market?

Major companies operating in the veterinary biomarkers market are Thermo Fisher Scientific Inc., Zoetis Inc., IDEXX Laboratories Inc., Antech Diagnostics Inc., Neogen Corporation, Heska Corporation, Olink Proteomics, SomaLogic, Life Diagnostics Inc., INDICAL BIOSCIENCE GmbH., Mercodia AB, Bionote USA Inc., Acuvet Biotech, Alertix Veterinary Diagnostics AB., MI:RNA Diagnostics Ltd., Veterinary Biomarkers Inc., Vetmaya Healthcare Private Limited, VolitionRx, BioVet Diagnostics, Randox Laboratories Ltd., Bio-Rad Laboratories Inc., QIAGEN N.V., FidoCure, Scil Animal Care Company GmbH, Shenzhen Mindray Animal Medical Technology Co. Ltd., Esaote SPA, Innovative Diagnostics SAS, Ayoxxa Biosystems

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-biomarkers-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Veterinary Biomarkers Market?

North America was the largest region in the veterinary biomarkers market in 2025. The regions covered in the veterinary biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Biomarkers Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20680&type=smp

Browse Through More Reports Similar to the Global Veterinary Biomarkers Market 2026, By The Business Research Company

Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-active-pharmaceutical-ingredients-manufacturing-global-market-report

Veterinary Dermatology Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-dermatology-drugs-global-market-report

Veterinary Dietary Supplements Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-dietary-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company